Re:McKinsey to pay $573M to settle claims over opioid crisis...
by asjldkfin on Thursday February 04, 2021 @09:58AM
(#26025819)
That's not how justice works; damning quotes determine guilt; not the magnitude of guilt.
Re:McKinsey to pay $573M to settle claims over opioid crisis...
by tyingq on Thursday February 04, 2021 @10:04AM
(#26025872)
It was a negotiated settlement, there weren't any pre-set rules on how the amount was agreed upon.
Re:McKinsey to pay $573M to settle claims over opioid crisis...
by asjldkfin on Thursday February 04, 2021 @10:14AM
(#26025968)
Except there is, a negotiation is based on the next best alternative; which is the legal system.
Mcks wouldn’t have settled for that much if they thought they’d fare better in court.
Re:McKinsey to pay $573M to settle claims over opioid crisis...
by tyingq on Thursday February 04, 2021 @10:19AM
(#26026022)
They didn't want it in court because it would have made a documented legal precedent around liability.
"One former partner called the settlement hugely significant because it shatters the distance that McKinsey — which argues that it only makes recommendations — puts between its advice and its clients’ actions. For decades, the firm has avoided legal liability for high-profile failures of some clients, including the energy company Enron and Swissair, Switzerland’s defunct national airline."
https://www.nytimes.com/2021/02/03/business/mckinsey-opioids...
Re:McKinsey to pay $573M to settle claims over opioid crisis...
by asjldkfin on Thursday February 04, 2021 @10:38AM
(#26026235)
1. I think that’s making a guess into their intentions which we’re not qualified to do
2. Even if we take #1 for granted, the $500MM figure is still based on something. The counter-party could’ve settled for $100MM or insisted on $1B but they reached that number for a reason.
Like this sort of thing:
"One was to give distributors a rebate for every OxyContin overdose attributable to pills they sold. The slides are notable for their granular detail.
For example, McKinsey estimated that 2,484 CVS customers would overdose or develop an opioid use disorder in 2019 from taking OxyContin. CVS said the plan was never implemented."
Not implemented, so didn't end up being effective. But damn.